Restarting Wegovy After 4 Weeks Off: What Happens Next

Why four weeks matters more than it might feel like

Semaglutide's pharmacology means the medicine accumulates in your system over weeks of regular dosing. Steady state (the point at which the drug's effects stabilise) takes several weeks to reach. When you stop, concentrations fall sharply. By the four-week mark, the active drug in your body is at a fraction of what it was at your last maintained dose.

That has a practical consequence beyond appetite returning. The gastrointestinal adaptation you worked through during titration (the nausea, the slowed digestion, the adjustment period) largely resets. Your gut has lost the accommodation it built up. Jumping straight back to, say, 1.7mg or 2.4mg carries a meaningful risk of significant nausea, vomiting and discomfort that could have been avoided by stepping back.

NHS guidance on semaglutide on the NHS medicines pages is clear that titration exists for tolerability, not just efficacy. The same logic applies in reverse when you restart. A four-week break is long enough that restarting from the beginning of the schedule, or at least from an earlier rung, is the norm rather than the exception.

Worth checking: if your gap was closer to two or three weeks, the picture may look different. Our guide to restarting after a shorter break covers that scenario separately. Equally, if your break landed closer to the three-week mark, our detailed guide to restarting Wegovy after three weeks may be a more precise fit for your situation, and if it stretched to around six weeks, we cover what restarting Wegovy after six weeks typically involves in a dedicated page.

The factors your prescriber weighs up

This is the core of the decision. No universal rule applies to everyone who has missed four weeks, because the right restart point depends on several things that vary between people.

First, how long were you at each dose before the break? Someone who had been stable at 1.0mg for eight weeks before stopping has a meaningfully different physiological baseline than someone who had just moved to 1.0mg the week before. Stability at a dose suggests the system had adjusted; a very recent increase suggests it hadn't fully settled.

Second, why did you stop? A planned pause for surgery is different from stopping because side effects became unbearable. If intolerance drove the break, simply restarting at the previous dose makes no sense. A prescriber will want to know this before suggesting any dose.

Third, have your circumstances changed? Weight, other medications, and any new health conditions all feed into the clinical picture. The prescriber reviewing your restart isn't just checking a box, a real clinician reads your history and makes a judgment, and that process matters more the longer the break has been.

If you had been on Wegovy for some time and want to understand how the medicine typically works over longer stretches, the Wegovy overview page has a thorough explanation of the treatment pathway.

What restarting at the right dose actually looks like

In practice, most people restarting after four weeks will be advised to go back to 0.5mg (sometimes 0.25mg) rather than the dose they were on when they stopped. The slower re-titration is not a setback; it is the route to getting back to your previous dose with far fewer side effects along the way.

The titration schedule for Wegovy typically moves in roughly four-week steps: 0.25mg, then 0.5mg, then 1.0mg, 1.7mg and 2.4mg maintenance. Some people stabilise at an intermediate dose; others reach 2.4mg without difficulty. How quickly you can re-escalate after a restart depends on how well each re-introduced dose is tolerated, and that assessment belongs with your prescriber, guided by how you feel week by week.

One thing patients tell us they wish they'd known: the first pen back in the routine tends to feel quite different from the last one before the break. Appetite suppression may feel stronger again, and GI sensitivity may be higher. Give your system time to re-adapt before concluding the dose feels wrong.

When your pen does arrive (plain, unbranded box, tracked by DPD) the Patient Information Leaflet inside covers storage and injection technique. Read it again if your break has been long enough that the details feel hazy.

When you should seek medical advice before restarting

Some situations call for a conversation before the next injection, not after. If you stopped because of severe or persistent stomach pain (particularly the kind that radiates to the back) that symptom should be assessed by a doctor before you resume treatment. The MHRA's guidance following its January 2026 Drug Safety Update on GLP-1 medicines specifically highlights acute pancreatitis as a known, though infrequent, serious side effect. A break prompted by that kind of pain deserves proper follow-up, not just a return to the lowest dose.

Similarly, if you've had surgery, started new medications, or had a significant change in weight or health since stopping, those factors belong in the conversation with a prescriber before you restart. Restarting semaglutide is not inherently complicated, but the specific details of your situation are exactly what a prescriber's review is for.

If a gap of four months rather than four weeks applies to your situation, the guidance shifts somewhat; our page on restarting after a much longer break addresses that directly.

For anyone working out whether to continue with Wegovy or explore a different treatment, the weight loss treatment consultation page is the right starting point. A prescriber at nume can review your history, recommend a restart dose, and ensure your plan is clinically sound before you take another injection. Cost context, including what a private Wegovy prescription typically involves, is covered on the Wegovy pricing page if that is relevant to your decision.